EverGlade Insights Blog
EverGlade Consulting (“EverGlade”), a national consulting firm, has successfully partnered with a global leader in mRNA materials used for research, diagnostics, and therapeutics, to successfully manage $39 million in federal funding. The Industrial Base Expansion...
As of August 10, the Center for Disease Control (CDC) reported that over 10,000 cases of monkeypox have been identified in the United States (US). The Biden administration officially declared monkeypox a Public Health Emergency...
With the government fiscal year ending in a few short weeks and Covid continuing to impact the country, new government funding opportunities are plentiful for organizations supporting both the pandemic response and other areas of...
EverGlade Consulting (“EverGlade”), a Washington, D.C. based consulting firm, has successfully aided Detect, Inc. (“Detect”) in securing a contract with BARDA for the advanced development of a next-generation diagnostic device which is an over-the-counter home...
With BARDA Industry Day kicking off on November 3, 2021, new opportunities abound for organizations supporting the pandemic response. These include an updated BARDA Broad Agency Announcement (“BAA”), a new Commercial Solutions Opening (“CSO”) from...
It seems that there may be a new Valley of Death on the horizon of COVID therapeutic development. Earlier this month (9 JUL) NIAID posted a Funding Opportunities Announcement soliciting proposals related to COVID therapeutic...